RNA5SP196: A Potential Drug Target and Biomarker (G100873458)

Target Name: RNA5SP196

NCBI ID: G100873458

RNA5SP196

Other Name(s): RN5S196 | RNA, 5S ribosomal pseudogene 196

RNA5SP196: A Potential Drug Target and Biomarker

RNA5SP196 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell adhesion and has been shown to play a role in various diseases, including cancer. This RNA molecule has also been identified as a potential biomarker for cancer diagnosis and treatment. In this article, we will explore the potential drug target of RNA5SP196 and its potential as a biomarker for cancer.

Potential Drug Target

RNA5SP196 has been shown to play a role in cell adhesion by regulating the activity of the protein E-cadherin. E-cadherin is a transmembrane protein that is involved in cell-cell adhesion. RNA5SP196 has been shown to regulate the activity of E-cadherin by binding to its N-terminus and preventing its interaction with the protein Z-catenin. This interaction between RNA5SP196 and Z-catenin is critical for the regulation of cell adhesion.

RNA5SP196 has also been shown to play a role in the regulation of cell migration. In various studies, researchers have shown that RNA5SP196 plays a positive role in the regulation of cell migration and has been shown to promote the migration of cancer cells. This suggests that RNA5SP196 may be a useful drug target for the treatment of cancer.

Potential Biomarker

RNA5SP196 has also been shown to serve as a potential biomarker for cancer. In various studies, researchers have shown that RNA5SP196 is expressed in various types of cancer, including breast, lung, and ovarian cancer. This suggests that RNA5SP196 may be a useful biomarker for the diagnosis and treatment of cancer.

RNA5SP196 has also been shown to have a positive impact on cancer cell survival. In various studies, researchers have shown that RNA5SP196 plays a role in the regulation of cell survival and has been shown to promote the survival of cancer cells. This suggests that RNA5SP196 may be a useful biomarker for the prediction of cancer outcomes.

Conclusion

In conclusion, RNA5SP196 is a non-coding RNA molecule that has been shown to play a role in cell adhesion and cancer regulation. Its potential as a drug target and biomarker makes it an attractive target for further research. Further studies are needed to fully understand the role of RNA5SP196 in cancer and its potential as a drug and biomarker.

Protein Name: RNA, 5S Ribosomal Pseudogene 196

The "RNA5SP196 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP196 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets